Voriconazole is a broad-spectrum triazole that is active against aspergillus species. We conducted a randomized trial to compare voriconazole with amphotericin B for primary therapy of invasive ...
New York, November 4, 2005 – Using Vfend® (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results